Rationale: Antiepileptic drugs are the mainstay of treatment for patients with epilepsy. Adherence to the prescribed regimen is a major factor in achieving a reduced seizure burden, which can decrease morbidity and mortality. Patients with epilepsy oftentimes complain about difficulty with memory. Because little is known about the relationship between memory and mood and adherence, the purpose of this project was to determine the impact of the confounding factors of memory and mood on antiepileptic drug adherence in patients with epilepsy. Methods: One hundred adult patients with epilepsy were recruited from the outpatient neurology clinic for this cross-sectional study. Patients who met the inclusion criteria completed measures of subjective memory (subset of 6 memory questions from the QOLIE-89) and objective memory (Hopkins Verbal Learning Test -Revised), subjective adherence (Morisky scale) and objective adherence (medication possession ratio), and mood (Neurological Disorders Depression Inventory for Epilepsy). Refill records from each patient's community pharmacy were used to objectively assess adherence. Medication possession ratios were calculated based on the antiepileptic drug refill records over the previous 6 months. Patients were considered adherent if their MPR was N 80%. Results: Women made up the majority of the sample (n = 59), and, on average, patients had been living with epilepsy for nearly 20 years. Approximately 40% of the sample were on antiepileptic drug monotherapy; most patients (N70%) took their antiepileptic drugs twice daily, and the mean number of total medications was 4.25 ± 2.98. Based on the objective measure of adherence, 35% of the patients were nonadherent. Patients self-reported better adherence than what was objectively measured. Only the retention metric of the objective memory measure differentiated adherent patients from nonadherent patients. Patients in the adherent group had significantly lower depression scores (indicating better mood) compared with those in the nonadherent group (p = 0.04). Conclusions: Objective memory measures were not robustly correlated with adherence. However, we observed that patients with higher depressed mood scores were more likely to be nonadherent. By targeting patients with epilepsy and comorbid depression, practitioners may identify patients at greatest risk of nonadherence and subsequent harm.
Introduction
Epilepsy is a common neurological problem affecting 1%-2% of the population. Antiepileptic drugs (AEDs) are the mainstay of treatment for patients with epilepsy, and adherence to the prescribed drug regimen is a major step in achieving a reduced seizure burden. Faught and colleagues have shown that decreased AED adherence is associated with more than a 3-fold increase in mortality [1] . Periods of nonadherence in patients with epilepsy were also associated with significantly more emergency department visits, hospital admissions, injuries, and fractures. A comprehensive review on AED adherence has recently been published [2] .
As in patients with epilepsy, medication adherence is an important determinant of reaching optimal outcomes in patients with chronic conditions. Adherence studies have been done in patients with other chronic diseases such as hypertension, heart disease, diabetes, arthritis, chronic obstructive pulmonary disease, asthma, depression, osteoporosis, and high cholesterol [3] .
The medication possession ratio (MPR) is a measure of adherence frequently utilized in the literature [1] . It is calculated by dividing the number of days of medication supplied within the refill interval by the number of days in the refill interval. The resulting value is typically between 0 and 1, with an MPR value N 0.8 being the widely accepted cutoff indicative of adherence.
The complex interaction of disease, treatment, and comorbid conditions is especially evident in the care of patients with epilepsy in tertiary care epilepsy centers. Despite verbal reports of adherence in most patients, in a small prospective project, six (54.5%) of 11 patients had a baseline AED MPR b 0.8 (unpublished data). Based on the current literature, the full contributors to adherence are unclear. There is extensive literature on memory dysfunction in patients with epilepsy, and recent data indicate that patients with epilepsy have a higher than previously detected level of concern with their memory [4] . An additional confounding factor is the interplay of mood with subjective and objective measures in patients with epilepsy [5] . To date, no literature that explores the relationship between these confounding factors and adherence in patients with epilepsy exists. The purpose of this project was to determine the impact of the confounding factors of memory and mood on AED adherence in patients with epilepsy.
Materials and methods
One hundred patients were recruited from the Ohio State University Wexner Medical Center's Comprehensive Epilepsy Program for this cross-sectional study. Institutional review board approval was obtained before any patients were recruited. Adult patients with epilepsy taking at least one AED for the prior 6 months and capable of providing consent and completing the surveys by themselves were recruited. The patients were also required to get their monthly AED refills from a community pharmacy.
Demographic and seizure activity data were gathered. As an incentive, all 100 patients were entered into a random drawing for four $25 gift certificates to a local store. Patients completed a brief battery of tests to assess memory (subjective and objective), mood, and selfreported adherence during their regularly-scheduled clinic appointment.
Memory
Subjective memory was assessed by asking the six memory domain questions from the validated Quality of Life in Epilepsy-89 questionnaire (QOLIE-89) which is reported as a percentage, with a higher score equating to better memory [6] . Objective memory was measured by the Hopkins Verbal Learning Test -Revised (HVLT-R), a brief assessment of recognition and recall for individuals 16 years and older. Recommended by the Epilepsy Common Data Elements group [7] , the HVLT-R has been validated within populations with brain disorders such as Alzheimer's, Parkinson's, and Huntington's diseases as a measure of verbal learning and memory [8] and has been found to be independently predictive of everyday instrumental activities of daily living, problem-solving, and psychomotor speed [9] . This test provides four measures: total recall, delayed recall, retention %, and recognition discrimination index. To determine if patients who report subjective memory complaints had a corollary deficit on an objective measure of memory, we compared each patient's QOLIE-89 subset score (subjective) with their HVLT-R score (objective). The HVLT-R total recall score (0 to 36) was converted into a percentage (HVLT-R %), and a difference score (subjective − objective) was calculated. A negative score reflects that the patient did better on the objective memory test than on the subjective memory test.
Mood
Mood was assessed by the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). This is a patient-answered six-item questionnaire that has been shown to be sensitive and specific in patients with epilepsy [10] . Lower scores represent better mood.
Adherence
Self-reported adherence was assessed by using the 4-question Morisky scale [11] and a visual analog scale (VAS). Morisky et al.
developed a brief, easily understood, and valid scale to be administered to patients in the clinical setting. Scores range from 0 to 4, with 4 depicting high and 0 depicting low medication-taking behavior. Patients were categorized into three groups: low (score of 0 or 1), medium (score of 2 or 3), and high (score of 4) scores. For the VAS, patients were asked to mark on a line anchored by "nonadherent" and "completely adherent" where they felt depicted their AED adherence. Their VAS score was calculated as a percent, with higher scores denoting better self-reported adherence. Patients were also given the opportunity to identify barriers and facilitators of their AED adherence (with the option to choose more than one response).
Each patient's community pharmacy provider was contacted to obtain their AED refill history records over the previous 6 months. This information was used to calculate each patient's AED MPR: the objective measure of adherence. For those patients on AED polytherapy, an average MPR was calculated. Based on MPRs, patients were separated into adherent (ADH) [MPR N 0.8] and nonadherent (non-ADH) [MPR b 0.8] categories. Refill histories were not gathered for non-AED medications.
Statistical analysis
Categorical data were subjected to chi-square analysis with between group comparisons of continuous data analyzed with Student's t-tests. Continuous variable correlations were measured using Pearson's correlation, and between-group comparisons of correlation were calculated using Fisher's method [12] .
Results

Demographics
A convenience sample of 100 patients was recruited. Their demographic information is summarized in Table 1 . Women made up the majority of the sample, and, on average, patients had been living with epilepsy for nearly 20 years. Approximately 40% of the sample were on AED monotherapy; most patients (N70%) took their AEDs twice daily, and the mean number of total medications was just over four. There were no demographic differences between the ADH patients and the non-ADH patients.
Adherence
Objective adherence data (individual MPR scores) are presented in Fig. 1 . Sixty-five patients had an MPR greater than or equal to 0.8 and, thus, were categorized as ADH. Patients' self-assessment of medication adherence (subjective adherence) via the Morisky score and VAS demonstrated that a majority of both the ADH patients and the non-ADH patients put themselves in the "medium" or in the "high" adherence category (Table 2) . When examining correlations between adherence measures, we correlated both the Morisky scores (r = 0.25, p = 0.005) and the VAS scores (r = 0.2, p = 0.02) with MPR. There was no difference in either subjective adherence score between the ADH group and the non-ADH group nor was there a significant difference between the groups in correlation of subjective adherence and Morisky (z = 0.003, NS) or VAS (z = 0.17, NS) scores.
When patients were asked to identify barriers to their adherence, a majority of each group (N70%) reported no adherence barriers (Fig. 2) . Ten percent of the entire sample identified cost as a barrier, though this was slightly higher (14.3%) in the non-ADH patients, possibly due to more patients in the latter group having income b $30,000 (77%) compared with the ADH group (54%). When patients were asked to identify adherence facilitators, the most common responses were "own routine" (59% of the sample) and a pillbox (52% of the sample) (Fig. 3) .
Memory
No differences existed between the ADH group and the non-ADH group for either the subjective memory scale (QOLIE-89 subset) or the objective measure (HVLT-R) ( Table 2 ). Discrete differences in memory functions were detected between the ADH group and the non-ADH group on one of the four measures of the HVLT-R. Retention T-scores were significantly lower in the non-ADH group (p = 0.03), and recognition discrimination index trended toward being lower in the non-ADH group (p = 0.09) [data not shown]. In the overall group, neither subjective nor objective memory scores were correlated with MPR. However, between-groups comparison of correlations demonstrated significant correlations of the subjective and objective scores within the ADH group (z = 2.42, p = 0.02) that was lacking in the non-ADH group (Table 3) .
When examining the relationship between the subjective scores and the objective scores, both the ADH group and the non-ADH group had a negative difference score (−4.64% and −9.24%, respectively). A majority of patients in both groups did better on the objective memory test (HVLT-R) than on the self-assessment memory measure. Fig. 4 is a scatter plot of individual difference scores by adherence category, showing little impact of adherence category on this measure. Table 2 illustrates the NDDI-E scores for each adherence group. Patients in the ADH group had significantly lower mood scores (indicating better mood) compared with those in the non-ADH group (p = 0.04). Depressive symptoms demonstrated a significant negative correlation with subjective memory scores (r = −0.52, p b 0.0001). No significant correlation was found between depressive symptoms and objective scores (data not shown). No between-groups comparison of correlation was significant.
Mood
Seizure activity
Fig . 5 depicts the seizure activity for our sample. Nearly 40% of the patients reported having seizures in the last month, and roughly about the same proportion were seizure-free for the last year. For purposes of data analyses, seizure activity was separated into 2 categories -(1) if it had been more than 12 months since their last seizure, patients were classified as "seizure-free" and (2) if their last seizure was within the last 12 months, they were classified as "not seizure-free". Chi-square analysis comparing seizure freedom with adherence captured a significant group-by-group interaction (p = 0.0003), with seizure-free patients more likely to be in the ADH group.
Discussion
Our project's primary purpose was to determine the impact of the confounding factors of memory and mood on AED adherence in patients with epilepsy. One would expect patients with epilepsy who are nonadherent to suffer from memory difficulties (compared with the adherent group) as memory is a key factor for patients to take their chronic medications. This was not the case in our study. Though we measured memory both objectively and subjectively, to our surprise, only retention (a specific measure from the HVLT-R) was significantly different between the ADH group and the non-ADH group. This suggests that memory may play only a small role in adherence. As is the case in other conditions, the relationship between memory and adherence is multifactorial and complex [13] .
When examining more closely the impact of mood on AED adherence, we found that the ADH patients were less depressed than those in the non-ADH group. The observed relationship between mood and adherence in our sample is consistent with data very recently published by Ettinger and colleagues [14] . Among other measures, they assessed mood (using the NDDI-E) and adherence (using MPRs) in a crosssectional study of 465 adult patients with epilepsy. They found that depression was correlated with an increased risk of nonadherence. The association between depression and poor adherence is not limited to patients with epilepsy [15, 16] . Proposed explanations include, but are not limited to; a sense of hopelessness, decreased motivation, and poor concentration [14] . It is more and more evident that mood plays a major role in the lives of patients with epilepsy. Previous evidence suggested its role in affecting quality of life more than seizures, and our data show its role in adherence [17] .
Our study showed that just over one-third (35%) of our patients were not adherent to their AEDs. This distinction was based on our chosen measure of objective adherence -their 6-month refill history (MPRs). Though these data are consistent with the literature where nonadherence to AEDs has been shown to range from 30% to 50%, it is not trivial as AED adherence influences morbidity and mortality [1] . As there is no "gold standard" for measuring adherence, Lehmann et al. suggest that "triangulation" of methods may increase the validity and reliability [18] . Interestingly, when we "triangulated" our data by using multiple methods of measuring adherence, we found a mismatch between self-reported adherence and objective adherence. Many of our patients overestimated how well they adhere to their medication regimen. Although the objective and subjective adherence measures demonstrated correlation in our overall sample, there was no differential correlation found between the ADH group and the non-ADH group, thereby indicating that perception of adherence was not a chief factor in determining a patient's adherence state. Though AED adherence may be routinely discussed during patient visits, there remains a significant gap between objective adherence and subjective adherence. Practitioners need to better understand this gap by differently querying their patients. Interestingly, this gap has been identified in conditions beyond epilepsy [19] . As with the adherence data, when we compared the objective and subjective memory data in our patient sample, a gap was discovered. A majority of patients in both groups did better on the objective memory test (HVLT-R) than on the self-assessment memory measure (QOLIE-89 subset), indicating that some patients who report memory complaints do not have a corollary deficit on an objective memory measure. Correspondence of performance in objective measures of memory with self-reported deficits is poor [20] . Though they did not use the same measures, Witt and colleagues reported that 44 (60%) of their 73 patients reported self-perceived memory deficits and that only 26 (36%) patients had objective memory impairment. Of note, they underscored the importance of factoring in mood when assessing memory. Marino and collaborators have shown that subjective perception of AED cognitive effects is more related to mood than to performance on objective neuropsychological tests [21] .
Our study is not without limitations. They include, but are not limited to, a cross-sectional study design, usage of single tools to assess subjective memory and objective memory, and a convenience sample of patients from one epilepsy center. We also recognize that obtaining refill records on our patients may not wholly indicate AED adherence [18] .
Conclusion
Objective memory measures were not robustly correlated with adherence. However, we observed that patients with higher depressed mood scores were more likely to be nonadherent. By targeting patients with epilepsy and comorbid depression, practitioners may identify patients at greatest risk of nonadherence and subsequent harm. Future studies should include the evaluation of supplemental adherence measures, such as reminder systems implemented through e-mails via patient portals, text messages, or phone calls. A recent review shows that eHealth interventions show promise [22] .
